Dr. Wiita is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
185 Berry St
China Basin UCSF Lab Medicine Box 0506
San Francisco, CA 94107Phone+1 415-353-1469
Education & Training
- University of California (San Francisco)Residency, Pathology-Anatomic and Clinical, 2009 - 2012
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2009
- Columbia UniversityPhD, Neurobiology/Biophysics, With Distinction, 2004 - 2008
- Princeton UniversityAB, Chemistry, Magna Cum Laude, 1998 - 2002
Certifications & Licensure
- CA State Medical License 2010 - 2026
- American Board of Pathology Pathology - Clinical
Awards, Honors, & Recognition
- Dale Frey Breakthrough Award Damon Runyon Cancer Research Foundation, 2015
- K08 Mentored Clinical Scientist Award NIH-National Cancer Institute, 2014
- Post-Doctoral Fellowship Award Damon Runyon Cancer Research Foundation, 2012
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsSLAPSHOT reveals rapid dynamics of extracellularly exposed proteome in response to calcium-activated plasma membrane phospholipid scrambling.Sami T Tuomivaara, Chin Fen Teo, Yuh Nung Jan, Arun P Wiita, Lily Y Jan
Communications Biology. 2024-08-29 - 2 citationsAlternative target recognition elements for chimeric antigen receptor (CAR) T cells: beyond standard antibody fragments.Matthew A Nix, Arun P Wiita
Cytotherapy. 2024-07-01 - Cell-Type Specificity of Mosaic Chromosome 1q Gain Resolved by snRNA-seq in a Case of Epilepsy With Hyaline Protoplasmic Astrocytopathy.Kun Leng, Cathryn R Cadwell, Walter P Devine, Tarik Tihan, Zhongxia Qi
Neurology. Genetics. 2024-04-01
Abstracts/Posters
- Ifitm3 Is Essential for PI(3,4,5)P3-Dependent B-Cell Activation and LeukemogenesisArun P. Wiita, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- In Vitro-Selected Nanobody-Based Cellular Therapy Targeting CD72 for Treatment of Refractory B-Cell MalignanciesArun P. Wiita, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Profiling the Cell Surface Landscape of Proteasome Inhibitor-Treated and _Resistant Multiple Myeloma to Guide Immunotherapy Targeting, Diagnosis, and BiologyArun P. Wiita, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
- Hutch Scientists Receive $25M to Solve Breast Cancer MetastasisJuly 27th, 2022
- Research Round-up: Multiple MyelomaNovember 25th, 2020
- Innovative Indian American Researchers Named 2016 NIH ‘New Innovator Award Program’ RecipientsOctober 28th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: